Peng Ying, Xu Yan, Yang Guangming, Li Shiwei, Rui Zhilian
Department of Clinical Laboratory, Liyang People's Hospital, Liyang 213300, People's Republic of China.
Department of Pathology, Liyang People's Hospital, Liyang 213300, People's Republic of China.
Onco Targets Ther. 2019 Nov 13;12:9599-9610. doi: 10.2147/OTT.S215543. eCollection 2019.
Various evidences showed that abnormally expressed long non-coding RNAs (lncRNAs) play important roles in the tumorigenesis and progression of malignancies. However, the exact role and regulatory mechanism of lncRNA TP73-AS1 in the pathogenesis and progression of lung adenocarcinoma remain to be further elucidated.
The aim of this study was to investigate the functional role and underlying mechanism of lncRNA TP73-AS1 in lung adenocarcinoma progression.
RT-PCR assay was employed to detect TP73-AS1 expression in lung adenocarcinoma tissues and cells. The function of TP73-AS1 in lung adenocarcinoma progression was estimated by MTT assay, EdU assay, flow cytometry, Western blot, wound-healing assay and transwell assay.
LncRNA TP73-AS1 expression was significantly increased in lung adenocarcinoma tissues and cell lines. Moreover, functional assays revealed that silencing of lncRNA TP73-AS1 could attenuate cell proliferation, migration, invasion and epithelial-mesenchymal transition of lung adenocarcinoma, while enhanced expression of lncRNA TP73-AS1 led to the opposite results. Additionally, lncRNA TP73-AS1 knockdown could facilitate cell apoptosis and overexpression of lncRNA TP73-AS1 inhibited cell apoptosis. In addition, we further determined that lncRNA TP73-AS1 regulated cell metastasis through inducing the activation of Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Our results indicated that lncRNA TP73-AS1 may play an oncogenic role in lung adenocarcinoma progression, which provided a promising therapy strategy for the treatment of lung adenocarcinoma.
各种证据表明,异常表达的长链非编码RNA(lncRNA)在恶性肿瘤的发生和发展中起重要作用。然而,lncRNA TP73-AS1在肺腺癌发病机制和进展中的确切作用及调控机制仍有待进一步阐明。
本研究旨在探讨lncRNA TP73-AS1在肺腺癌进展中的功能作用及潜在机制。
采用RT-PCR检测肺腺癌组织和细胞中TP73-AS1的表达。通过MTT法、EdU法、流式细胞术、蛋白质免疫印迹法、伤口愈合试验和Transwell试验评估TP73-AS1在肺腺癌进展中的作用。
lncRNA TP73-AS1在肺腺癌组织和细胞系中表达显著增加。此外,功能试验表明,沉默lncRNA TP73-AS1可减弱肺腺癌细胞的增殖、迁移、侵袭及上皮-间质转化,而增强lncRNA TP73-AS1的表达则产生相反结果。此外,lncRNA TP73-AS1敲低可促进细胞凋亡,而lncRNA TP73-AS1过表达则抑制细胞凋亡。另外,我们进一步确定lncRNA TP73-AS1通过诱导肺腺癌中Wnt/β-连环蛋白信号通路的激活来调节细胞转移。
我们的结果表明,lncRNA TP73-AS1可能在肺腺癌进展中发挥致癌作用,这为肺腺癌的治疗提供了一种有前景的治疗策略。